AMD (NASDAQ:AMD) today announced financial results for the third quarter of 2025. Third quarter revenue was a record $9.2 billion, gross margin was 52%, operating income was $1.3 billion, net income ...

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

But I’m currently laid up with the Acer Predator Triton 14 AI on my knee, listening to John Coltrane put his soul into his ...

Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that its SOL-R registrational trial of ...

Asian markets fell Tuesday as investors assessed the latest tech rally on Wall Street amid worries a bubble is forming in the sector, while mixed signals from Federal Reserve officials ...

Advanced Micro Devices forecast fourth-quarter revenue above market estimates on Tuesday, betting on the multibillion-dollar ...

In addition to ongoing successes with processors, AMD is now selling more Radeon graphics cards again. However, the stock is ...

Advanced Micro Devices forecast fourth-quarter revenue above market estimates on Tuesday, betting on the multibillion-dollar ...

Enthusiasm about artificial intelligence and the companies that produce AI services has been overflowing for months.

Shares of Advanced Micro Devices (NASDAQ: AMD) rose 58.3% in October 2025, according to data from S&P Global Market ...

Based on subdued expectations and consumer sentiment, Nike’s stock has been under pressure. Over the past 52 weeks, the stock ...